Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum

Experimental Brain Research

Volumn 116, Issue 1, 1997, Pages 29-38

  Granholm, A C ^a   Mott, J L ^a   Bowenkamp, K ^a   Eken, S ^a   Henry, S ^a   Hoffer, B J ^b   Lapchak, P A ^c   Palmer, M R ^a   Van Horne, C ^d   Gerhardt, G A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c AMGEN INC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Glial cell line derived neurotrophic factor; Neurotrophic factors; Nigrostriatal dopaminergic pathway; Striatum; Transplants

Indexed keywords

APOMORPHINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; FETUS; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INNERVATION; MALE; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL SIZE; CELL SURVIVAL; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; RATS; RATS, INBRED F344;

EID: 8544253929     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005741     Document Type: Article

References (73)

1. Agnati LF, Fuxe K, Calza L, Benfenati F, Cavicchioli L, Toffano G (1983) Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol Scand 119: 347-363
2. Attisano L, Wrana JL, Lopez-Casillas F, Massague J (1994) TGF-β receptors and action. Minireview. Biochim Biophys Acta 1222: 71-80
3. Bäckman C, Biddle PT, Ebendal T, Friden PM, Gerhardt GA, Henry MA, Mackerlova L, Söderström S, Strömberg I, Walus L, Hoffer BJ, Granholm A-C (1995) Effects of transferrin receptor-antibody-NGF conjugate on young and aged septal transplants in oculo. Exp Neurol 132: 1-15
4. Bäckman C, Rose GM, Hüfter BJ, Henry MA, Bartus RT, Friden P, Granholm A-C (1996) Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J Neurosci 16: 5437-5442
5. Bakay RA, Sladek JR (1993) Fetal tissue grafting into the central nervous system: yesterday, today and tomorrow. Neurosurgery 33: 645-647
6. Bergman H, Nagy JI, Granholm A-C (1995) Intracranial transplantation and survival of tuberomammillary histaminergic neurons. Neuroscience 64: 61-70
7. Borlongan CV, Cahill DW, Freeeman TB, Sanberg PR (1994) Recent advances in neural transplantation: Relevance to neurodegenerative disorders. J Florida Med Assoc 81: 689-694
8. Bothwell M (1991) Keeping track of neurotrophin receptors. Cell 65: 915-918
9. Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm AC (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 355: 479-489
10. Carvey PM, Ptak LR, Kao LC, Klawans HL (1989) Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in rostral mesencephalic tegmental cultures. Clin Neuropharmacol 124: 425-434
11. Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL (1993) Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol 120: 149-152
12. Choi-Lundberg DL, Bohn MC (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in the rat. Brain Res Dev Brain Res 85: 80-88
13. Collier TJ, Springer JE (1994) Neural graft augmentation through co-grafting: implantation of cells as sources of survival and growth factors. Prog Neurobiol 44: 309-331
14. Commissiong JW, Toffano G (1986) The effect of GM1 ganglioside on coeruleospinal, noradrenergic, adult neurons and on fetal monoaminergic neurons transplanted into the transected spinal cord of the adult rat. Brain Res 380: 205-215
15. Conner JM, Varon S (1992) Distribution of nerve growth factor-like immunoreactive neurons in the adult rat brain following colchicine treatment. J Comp Neurol 326: 347-362
16. Date I, Notter MFD, Felten SY, Felten DL (1990) MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res 526: 156-160
17. Date I, Ohmoto T, Imaoka T, Ono T, Hammang JP, Francis J, Greco C, Emerich DF (1996a) Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J Neurosurg 84: 1006-1012
18. Date I, Imaoka T, Miyoshi Y, Ono T, Asari S, Ohmoto T (1996b) Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. J Neurosurg 84: 685-689
19. Defer GL, Geny C, Ricolfi F, Fenelon G, Monfort JC, Remy P, Villafane G, Jeny R, Samson Y, Keravel Y, Gaston A, Degos JD, Peshanski M, Cesaro P, Nguyen JP (1996) Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119: 41-50
20. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V (1996) GDNF-signalling through the Ret receptor tyrosine kinase. Nature 381: 789-793
21. Freeman TB, Sanberg PR, Nauert GM (1995) The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant 4:141-154
22. Friedman WJ, Ibanez CF, Hallbook F, Persson H, Cain LD, Dreyfus CF, Black IB (1993) Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol 119: 72-78
23. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252-255
24. Haque NS, Hlavin ML, Fawcett J, Dunnett SB (1994) The effect of neurotrophin 5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease. Gene Ther [Suppl I]: S60
25. Heim RC, Willingham G, Freed WJ (1993) A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with baseline rotational behavior. Exp Neurol 122: 5-15
26. Hitchcock E (1995) Current trends in neural transplantation. Neurol Res 17: 33-37
27. Hoffer BJ, Hoffman AF, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin L-F, Gerhardt GA (1994) Glial cell-line derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182: 107-111
28. Hudson JL, van Horne CG, Strömberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA (1993a) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626: 167-174
29. Hudson JL, Levin DR, Hoffer BJ (1993b) A 16-channel automated rotometer system for reliable measurement of turning behavior in 6-hydroxydopamine lesioned and transplanted rats. Cell Transplant 2: 507-514
30. Hudson JL, Granholm A-C, Gerhardt GA, Henry MA, Hoffman AF, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, Hoffer BJ (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36: 425-432
31. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopolous GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230-232
32. Jaeger C, Ruiz G, Llinas R (1989) Organotypic slice cultures of dopaminergic neurons of substantia nigra. Brain Res Bull 22: 981-991
33. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis J-C, Hu S, Altrock BW, Fox GM (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85: 1113-1124
34. Johansson M, Friedemann M, Hoffer BJ, Strömberg I (1995) Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp Neurol 134: 25-34
35. Kearns CM, Gash DM (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672: 104-111
36. Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88: 961-965
37. Kordower JH, Charles V, Bayer R, Bartus RT, Putney S, Walus LR, Friden PM (1994) Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington's disease. Proc Natl Acad Sci USA 91: 9077-9080
38. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, et al (1995) Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332: 1118-1124
39. Kupsch A, Oertel WH (1994) Neural transplantation, trophic factors and Parkinson's disease. Life Sci 55: 2083-2095
40. Lapchak PA, Miller PJ, Jiao S, Araujo DM, Hilt D, Collins F (1996) Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease? Neurodegeneration 5: 197-205
41. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132
42. Lindner MD, Winn SR, Baetge EE, Hammang JP, Gentile FT, Doherty E, McDermot PE, Frydel B, Ullman MD, Schallert T (1995) Implantation of encapsulated calecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp Neurol 132: 62-76
43. Lindvall O (1994) Clinical application of neuronal grafts in Parkinson's disease. J Neurol 242: 54-56
44. Lindvall O, Sawle G, Widner H, Rothwell JC, Björklund A, Brooks D, Brundin P, Frackowiak R, Marsden CD, Odin P (1994) Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35: 172-180
45. Lo ES, Ptak LR, Nath ST, Mufson EJ, Klawans HL, Carvey PM (1990) A striatal-derived neurotrophic factor: relationship to Parkinson's disease. Soc Neurosci Abstr 16: 809
46. Lopez-Lozano JJ, Bravo GG, Brera B, Dargallo J, Salmean J, Uria J, Insausti J, Millan I (1995) Long-term follow-up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus: the Clinica Puerta de Hierro experience. CPH Neural Transplantation Group. Transplant Proc 27: 1395-1400
47. Marshall JF, Ungerstedt U (1977) Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model. Eur J Pharmacol 41: 351-367
48. Meyer CH, Detta A, Kudoh C (1995) Hitchcock's experimental series of foetal implants for Parkinson's disease: cografting ventral mesencephalon and striatum. Acta Neurochir Suppl (Wien) 64: 1-4
49. Nikkah G, Brandeis A (1995) Neurotransplantation in Parkinson disease: experimental and clinical results of functional reconstruction of the dopaminergic system. Zentralbl Neurochir 56: 153-160
50. Olson L, Backman L, Ebendal T, Eriksdotter-Jonhagen M, Hoffer B, Humpel C, Freedman R, Giacobini M, Meyerson B, Nordberg A (1994) Role of growth factors in degeneration and regeneration in the central nervous system: clinical experiences with NGF in Parkinson's and Alzheimer's disease. J Neurol 242: 12-15
51. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
52. Price ML, Hoffer BJ, Granholm A-C (1996) Effects of GDNF on fetal septal forebrain transplants in oculo. Exp Neurol 141: 181-189
53. Prochiantz A, Dauget M-C, Herbert A, Glowinski J (1991) Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurons by striatal membranes. Nature 293: 570-572
54. Roberts AB, Sporn MB (1990) In: Roberts AB, Sporn MB (eds) Peptide growth factors and their receptors. Springer, Berlin Heidelberg New York, pp 419-472
55. Robertson GS, Robertson HA (1989) Evidence that L-DOPA-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9: 3326-3331
56. Robertson GS, Herrera DG, Dragunow M, Robertson HA (1989) L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur J Pharmacol 159: 99-100
57. Rosenstein JM (1995) Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation. Exp Neurol 133: 1-6
58. Sauer H, Rosenblad C, Björklund A (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA 92: 8935-8939
59. Sautter J, Kupsch A, Oertel WH, Earl CD (1995) Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology. Zentralbl Neurochir 56: 161-167
60. Schaar DG, Sieber B-A, Dreyfus CJ, Black IB (1993) Regional and cell-specific expression of GDNF in rat brain. Exp Neurol 124: 368-371
61. Sheng JG, McShane LM, Plunkett RJ, Cummins AC, Oldfield EH, Kopin IJ, Palmatier MA (1993) Dopaminergic neuronal sprouting and behavioral recovery in hemiparkinsonian rats after implantation of amnion cells. Exp Neurol 123: 192-203
62. Sinclair SR, Clive CA, Svendsen N, Torres EM, Fawcett JW, Dunnett SB (1996) GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport 7: 2547-2552
63. Springer JE, Mu X, Bergmann LW, Trojanowski JQ (1994) Expression of GDNF in rat and human nervous tissues. Exp Neurol 127: 167-170
64. Strömberg I, Björklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer BJ, Humpel C (1993) Glial cell-line derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124: 401-412
65. Strömberg I, Johnson S, Hoffer BJ, Olson L (1985a) Reinnervation of dopamine-denervated striatum by substantia nigra transplants: immunohistochemical and electrophysiological correlates. Neuroscience 14: 981-990
66. Strömberg I, Ebendal T, Seiger Å, Olson L (1985b) Nerve fiber production by intraocular adrenal medullary grafts: Stimulation by nerve growth factor or sympathetic denervation of the host iris. Cell Tissue Res 241: 241-249
67. Takahashi M, Asai N, Iwashita T, Isomura T, Miyazaki K, Matsuyama M (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8: 2925-2929
68. Tomac A, Lindqvist E, Lin L-F, Ögren S, Young D, Hoffer BJ, Olson L (1995) Promotion and repair of the nigrostriatal dopaminergie system by GDNF in vivo. Nature 373: 335-339
69. Tomozawa Y, Appel SH (1986) Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res 399: 111-124
70. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A (1996) Characterization of a multicomponent receptor for GDNF. Nature 382: 80-83
71. Trupp M, Arenas E, Fainzilber M, Nilsson A-S, Sieber B-A, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, Sariola H, Saarma M, Ibanez CF (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381: 785-789
72. Ungerstedt U, Arbuthnolt GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res 24: 485-493
73. Yurek DM, Lu W, Hipkens S, Wiegand SJ (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine cells. Exp Neurol 137: 105-118